Regent Pacific Continues Successful Efforts to Commercialise Fortacin™ in Asia

Licence Agreement with Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. to Launch Fortacin™, a Breakthrough Premature Ejaculation Treatment in Chin

Breakthrough Premature Ejaculation Treatment Fortacin™ to Launch in Hong Kong and Macau in Early 2019

Regent Pacific Announces 2018 Interim Financial Results Commercialisation of Fortacin™ in Europe continues; significant progress in Macau and Hong Kong

Regent Pacific Announces 2017 Annual Financial Results
Good Progress on Strategic Transformation as Global Fortacin™ Rollout Commenced

Regent Pacific’s Flagship Treatment Fortacin™ Debuts in Continental Europe